Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Influence of the primary disease on rehabilitation results in early postoperative period in patients post orthotopic liver transplantation

W Rongies, S Stępniewska, B Golińska, T Kenczew-Kolanowska, A Brudkowska, T Jakimowicz, W Dolecki, M Krawczyk, M Federowicz

Ann Transplant 2009; 14(1): 39-39 :: ID: 880339

Abstract

Background: Rehabilitation after orthotropic liver transplantation (OLTx) is a
difficult clinical problem due to severe co-morbidities and complications. Aim of the study: Evaluation of the rehabilitation progress in early postoperative period in patients after OLTx depending on the reason of liver transplantation.
Material/Method: 309 OLTx recipients transplanted between 2003 and 2006 were evaluated retrospectively. There were 161 women and 148 men. We analyzed results of early postoperative rehabilitation measured by time of achieving full active upright position by the patient after surgery. We divided our patients into 5 groups due to aetiology of liver failure. Group A (n=89, mean age 46.7 years) consisted of patients with liver cirrhosis due to hepatitis B, C or both. Group B (n=70, mean age 43.8 years) was patients with primary biliary cirrhosis and primary sclerosing cholangitis. Group C (n=44, mean age 46 years) - patients with post-alcoholic liver cirrhosis, group D (n=23, mean age 29.7) with acute and sub acute liver failure and group E (n=83, mean age 37.4 years) with other reasons of liver failure. All patients were included in identical rehabilitation program.
Results: Mean time of achieving full active upright position of the patient was
dependent on the reason of liver failure. The best results were in group A and
E. The difference was statistically signifi cant between group A, E and D.
Conclusions: Rehabilitation results in early postoperative period in patients after OLTx are dependent on primary liver disease.

Keywords: ethical aspects, Liver Transplantation

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358